8:45am ET
Investing
Johnson & Johnson Just Paid Investors: Here’s How Much They Got
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
ABBV Coverage Page 12
10:32am ET
Investing
Market Correction Wake-Up Call? 4 Dependable High-Yield Dividend Kings to the Rescue
One solid idea for growth and income investors who want to stay invested but shift to a more balanced approach is to look at the incredible Dividend Kings.
8:45am ET
Investing
AbbVie Just Paid Investors: Here’s How Much They Received
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
11:18am ET
Investing
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today
Live Updates Deep Dive into ABBV's Earnings Call 11:53am ETRich DupreyLooking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set to Dominate Immunology Market 2025 revenue projection:…
7:45am ET
Investing
Merck Just Paid Investors: How Much Did They Receive?
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
10:15am ET
Investing
Johnson & Johnson Just Paid Investors: Here’s How Much They Received
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
8:15am ET
Investing
Baby Boomers Can Retire in the Best America in Decades: 5 Dividend King Stocks for Their Journey
Some of the best stocks for income investors are the Dividend Kings. Here are five that are perfect for retired baby boomers now.
11:46am ET
Investing
One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays
Donald Trump’s victory is positive for the stock market. The healthcare sector has underperformed and offers enormous upside. Healthcare stocks pay some of the most reliable dividends. Proper asset allocation should include…
12:39pm ET
Investing
Dividend Aristocrats Yielding Over 4% to Buy in November
Companies with high dividend yields are relatively uncommon in this market. In fact, the average yield on the S&P 500 (albeit one which is heavily weighted toward tech stocks) is around 1.2%.…
10:52am ET
Investing
Can This Dividend King Ever Hit $400 After This Major Fail?
24/7 Wall St. Insights: AbbVie (ABBV | ABBV Price Prediction) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s…
9:10am ET
Investing
Dividend King AbbVie Just Paid Investors: Here’s How Much They Got
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
9:59am ET
Investing
Dividend Aristocrat AbbVie Just Paid Investors; Here’s How Much They Received
AbbVie Inc. (NYSE: ABBV) | ABBV Price Prediction is rewarding its shareholders once again with a quarterly dividend of $1.55, payable on Tuesday Oct. 15th. While investors will wait to hear about…
Joel South 8:11am ET
Investing
3 Top Pharma Stocks to Buy in October 2024
The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma companies…
9:15am ET
Investing
Prediction: This Will Be the Biggest Pharma Stock in 10 Years
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
7:43am ET
Investing
3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024
The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled Nvidia (NASDAQ:NVDA | NVDA Price Prediction) to the forefront of the industry.…